Evidence map›Paper›PMID 38532459›Full record

ArticleCell & bioscience2024

Unveiling the functional heterogeneity of cytokine-primed human umbilical cord mesenchymal stem cells through single-cell RNA sequencing.

Zhiwei Hu, Duanduan Li, Shiduo Wu, Ke Pei, Zeqin Fu, Yulin Yang, Yinfu Huang, Jian Yang, Chuntao Liu, Junyuan Hu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell & bioscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 2 countries.

Zhiwei Hu *Shenzhen Beike Biotechnology Co., Ltd, Shenzhen, 518054, China.
Duanduan Li *Shenzhen Beike Biotechnology Co., Ltd, Shenzhen, 518054, China.
Shiduo Wu *Shenzhen Beike Biotechnology Co., Ltd, Shenzhen, 518054, China.
Ke PeiShenzhen Beike Biotechnology Co., Ltd, Shenzhen, 518054, China.
Zeqin FuShenzhen Beike Biotechnology Co., Ltd, Shenzhen, 518054, China.
Yulin YangShenzhen Beike Biotechnology Co., Ltd, Shenzhen, 518054, China.
Yinfu HuangShenzhen Beike Biotechnology Co., Ltd, Shenzhen, 518054, China.
Jian YangShenzhen Beike Biotechnology Co., Ltd, Shenzhen, 518054, China.
Chuntao LiuShenzhen Beike Biotechnology Co., Ltd, Shenzhen, 518054, China.
Junyuan HuShenzhen Beike Biotechnology Co., Ltd, Shenzhen, 518054, China.
Cheguo CaiShenzhen Beike Biotechnology Co., Ltd, Shenzhen, 518054, China. cheguo_cai@ucas.ac.cn.
Yan LiaoShenzhen Beike Biotechnology Co., Ltd, Shenzhen, 518054, China. liaoyan@beike.cc.ORCID http://orcid.org/0000-0003-3778-2088
Beike Biotechnology (China) · CN

Funding

Basic and Applied Basic Research Foundation of Guangdong Province 2021A1515011108Shenzhen Science and Technology Innovation Program KJZD20230923114504008
6 · The paper itself

Abstract

backgroundMesenchymal stem cells (MSCs) hold immense promise for use in immunomodulation and regenerative medicine. However, their inherent heterogeneity makes it difficult to achieve optimal therapeutic outcomes for a specific clinical disease. Primed MSCs containing a certain cytokine can enhance their particular functions, thereby increasing their therapeutic potential for related diseases. Therefore, understanding the characteristic changes and underlying mechanisms of MSCs primed by various cytokines is highly important.

resultsIn this study, we aimed to reveal the cellular heterogeneity, functional subpopulations, and molecular mechanisms of MSCs primed with IFN-γ, TNF-α, IL-4, IL-6, IL-15, and IL-17 using single-cell RNA sequencing (scRNA-seq). Our results demonstrated that cytokine priming minimized the heterogeneity of the MSC transcriptome, while the expression of MSC surface markers exhibited only slight changes. Notably, compared to IL-6, IL-15, and IL-17; IFN-γ, TNF-α, and IL-4 priming, which stimulated a significantly greater number of differentially expressed genes (DEGs). Functional analysis, which included Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, indicated that IFN-γ, TNF-α, and IL-4-primed hUC-MSCs are involved in interferon-mediated immune-related processes, leukocyte migration, chemotaxis potential, and extracellular matrix and cell adhesion, respectively. Moreover, an investigation of various biological function scores demonstrated that IFN-γ-primed hUC-MSCs exhibit strong immunomodulatory ability, TNF-α-primed hUC-MSCs exhibit high chemotaxis potential, and IL-4-primed hUC-MSCs express elevated amounts of collagen. Finally, we observed that cytokine priming alters the distribution of functional subpopulations of MSCs, and these subpopulations exhibit various potential biological functions. Taken together, our study revealed the distinct regulatory effects of cytokine priming on MSC heterogeneity, biological function, and functional subpopulations at the single-cell level.

conclusionsThese findings contribute to a comprehensive understanding of the inflammatory priming of MSCs, paving the way for their precise treatment in clinical applications.

Indexed as

Cell heterogeneityCytokine primingFunctional subpopulationsMesenchymal stem cells (MSCs)Single-cell RNA sequencing (scRNA-seq)

Identifiers

PMID38532459
PMCPMC10964690
OpenAlexW4393199740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.